2021-07-30 11:15
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the annual general meeting on Tuesday 31 August 2021. Information with respect to the coronavirus The Company is mindful of the health...
2021-06-30 08:00
Annual report for the financial year 2020/2021 for Biovica International AB is published today on our website Financials – Biovica Contact Anders Rylander, CEO Phone: +46-18-444 48 35 E-mail: anders.rylander@biovica.com Cecilia Driving, EVP CFO...
2021-06-17 08:00
Preparations for the launch of DiviTum®TKa Significant events during the fourth quarter Significant events after the end of the period Audiocast: When: 18 June 2021 at 10.00 CET Where: https://tv.streamfabriken.com/biovica-international-q4-2020-2021...
2021-05-22 14:30
Biovica, active in cancer diagnostics, will host a virtual Capital Markets Day on Wednesday 9 June from 14.00 to 16.30. Biovica is approaching market launch of DiviTum®TKa in the US for the monitoring of metastatic breast cancer treatments. Today...
2021-05-20 08:00
May 20, 2021 - Biovica, active in cancer diagnostics, today announces that DiviTumTKa shows prognostic and predictive capabilities in metastatic cutaneous melanoma patients undergoing immunotherapy. These results from a new study at Karolinska University...
2021-04-29 11:00
Biovica, active in cancer diagnostics, today announced that the company has strengthened the management team with Helle Fisker as new commercial manager and Joakim Arwidson as new quality and regulatory manager. Helle Fisker has more than 25 years of...
2021-04-23 08:30
Biovica, active in cancer diagnostics, today announced that the results from a budget impact model of monitoring with DiviTum®TKa can give savings of up to three times the extra spend relative to current management. The results will be presented at...
2021-03-18 08:00
FDA resumes review of DiviTum®TKa submission Significant events during the third quarter Significant events after the end of the period Audiocast: When: 18 March 2021 at 10.00 CET Where: https://tv.streamfabriken.com/biovica-international-q3-2020-2021...
2021-03-11 11:10
Biovica, active in cancer diagnostics, today announced that the results from the breast cancer study PROMIX at Karolinska University Hospital is published in the scientific journal ESMO Open. The study showed that testing for TKa levels during early treatment...
2021-02-26 08:00
The Nomination Committee prior to the 2021 Annual General Meeting will consist of three members, who shall represent the two shareholders with the most number of shares who accept the assignment to be part of the Nomination Committee as of December 31...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects